Iraq vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Iraq
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Iraq rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iraq
- Kazakhstan
How they compare
Iraq currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2007 it was Kazakhstan ahead.
Iraq ranks 1st and Kazakhstan ranks 1st of 180 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.7% | 49.3% | 31.6% | Kazakhstan |
| 2010s | 59.4% | 87.4% | 28.0% | Kazakhstan |
| 2020s | 97.6% | 100.0% | 2.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iraq or Kazakhstan?
- Iraq, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iraq and Kazakhstan?
- 0.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Kazakhstan?
- 18 years are reported by both, from 2007 to 2024.
- How do Iraq and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Iraq ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.